Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix immunogenicity study in at-risk children and healthy young children
2011-006013-34Phase 3
- Sponsor
- GSK
- Start
- Jan 2013
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease, invasive pneumococcal disease (IPD), sponsored by GSK.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal diseaseinvasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on 2011-006013-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006013-34.